Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
NCT06705543

Antenatal Investigation of Fetuses With Complex Congenital Heart Defects Using multiOMICS

Led by University Hospital, Bordeaux · Updated on 2025-04-10

40

Participants Needed

2

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will use multiOMICS study on fetuses with complexe congenital heart defects (CHD) to identify etiological epigenetic factors of these cardiac malformations, related to environmental factors during pregnancy.

CONDITIONS

Official Title

Antenatal Investigation of Fetuses With Complex Congenital Heart Defects Using multiOMICS

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women aged 18 years or older
  • Single fetal pregnancy with a complex non-syndromic congenital heart defect and no identified chromosomal abnormality, gene syndrome, or infection
  • Indication for amniocentesis accepted by the CPDPN and the patient/couple
  • Gestational age between 20 and 28 weeks
  • Person affiliated with or benefiting from a social security scheme
  • Free, informed, and written consent provided before any research examination
  • For control group: pregnant women aged 18 or older with non-malformative ultrasound anomalies and no chromosomal anomaly, gene syndrome, or infection identified
  • Control group patients with indication for amniocentesis accepted by CPDPN and patient/couple
  • Control group gestational age between 20 and 28 weeks
  • Control group persons affiliated with or benefiting from social security
  • Control group free, informed, and written consent provided before any research examination
Not Eligible

You will not qualify if you...

  • Female minors
  • Patients not affiliated with the social security system
  • Patients who do not understand French
  • Patients under guardianship
  • Multiple pregnancies or fetuses with associated malformations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU de Bordeaux

Bordeaux, France, 33076

Actively Recruiting

2

CHU de Nantes

Nantes, France, 44093

Not Yet Recruiting

Loading map...

Research Team

C

Caroline ROORYCK-THAMBO, PROF

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here